MedPath

Monitoring fetal-to-neonatal pulmonary transition after birth with transcutaneous electromyography of the diaphragm

Completed
Conditions
Pulmonary transition
respiratory distress
10028971
Registration Number
NL-OMON48881
Lead Sponsor
Academisch Medisch Centrum
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
30
Inclusion Criteria

-Infants who are born,older than 26 weeks, and need monitoring of the pulmonary
transition
-Written parental informed consent acquired antenatal or deferred.

Exclusion Criteria

- Major congenital anomaly that prevents placement of EMG electrodes
- Patients for whom life support will be witheld or withdrawn at birth will not
be included

Study & Design

Study Type
Observational non invasive
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<p>The feasibility of dEMG - recording in the delivery room (Signal quality of<br /><br>dEMG) during pulmonary transition expressed as the accuracy in heart rate and<br /><br>respiratory rate. </p><br>
Secondary Outcome Measures
NameTimeMethod
<p>Secondary endpoints are:<br /><br>- Description of changes in electrical activity (peak, amplitude, tonic<br /><br>activity, etc.) of the diaphragm during the transition.<br /><br>- Comparison in timing of heart rate detection acquired by EMG, compared to CI<br /><br>and PO, in order to find out which method is the fastest in detecting heart rate<br /><br>- Besides heart rate monitoring and breathing monitoring, other parameters from<br /><br>the standard-of-care respiratory function monitor (RFM) are studied as well in<br /><br>order to investigate the effect of respiratory support on diaphragmatic<br /><br>activity.</p><br>
© Copyright 2025. All Rights Reserved by MedPath